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Clinical History
A 32 year-old woman presented to Accident and Emergency, in the evening, due to an acute
exacerbation of chronic right iliac fossa pain. The pain had started two years previously. There was
no relevant medical or drug history. On examination there were no significant findings.
Imaging Findings
Ultrasound (US) (Fig. 1) revealed a large septated cystic mass that occupied the right iliac fossa and
the right side of the pelvic cavity. 
Computed tomography (CT) (Fig. 2) demonstrated a low-density, well-defined mass that pushed the
pelvic organs towards the contra-lateral side.
Magnetic resonance (MR) imaging (Fig. 3) showed a high signal mass on T2WI, with septa lacking
invasive characteristics. 
The right ovary was not identified on any of the imaging techniques. 
Further imaging studies did not reveal any other lesions, namely lung or kidney involvement.
The patient underwent surgery in order to remove the cystic mass. Histopathologic analysis was
performed, showing smooth muscle cells proliferation encasing lymphatic tissue.
Discussion
Lymphangioleiomyomatosis (LAM) is a rare systemic disorder characterised by the proliferation of
bundles of smooth muscle cells around vessels and lymphatics. It affects almost exclusively women
during childbearing years. There is no clear hereditary pattern, but it seems likely that the
pathogenesis is associated with a mutation in the somatic TSC2 gene. Increased oestrogen states,
such as pregnancy or therapy with exogenous oestrogens, seem to be associated with disease
progression. However, oestrogen blockers have, thus far, shown little effect on disease control .(1, 2)
LAM's most common manifestations, such as exertional dyspnoea and pneumothorax, are due to
pulmonary involvement. Approximately half of the patients diagnosed with LAM have abdominal
involvement . Abdominal symptoms can, rarely, predate lung disease .(1) (2)
Abdominal manifestations of the disease include :(1-3)
- Renal angiomyolipomas, which are usually multiple, bilateral and symmetrical, occur in 20-54%
of patients . US, unenhanced CT and MR can accurately diagnose angiomyolipomas, due to the(1)
fat content. However, the absence of fat does not exclude the diagnosis. Multiple tumours and those
larger than 4cm are more likely to increase and be symptomatic. Symptoms are due to haemorrhage
resulting in pain, haematuria and hypovolaemic shock.
- Lymphangioleiomyomas are cystic masses resulting from the dilatation of lymphatic vessels due
to obstruction by the proliferation of smooth muscle cells. They are more common in the abdomen,
retroperitoneum and pelvis, but can occur in the mesdiastinum and neck. These occur in 20% of
patients diagnosed with LAM . Their size and wall thickness vary. They differ from(1)
lymphangiomas in that the latter lack smooth cells on their walls. Patients usually present with
nausea, bloating, abdominal distension, peripheral oedema and urinary symptoms. These symptoms
may worsen during the day, due to the increase in size of the lymphangioleiomyomas. About 10%
of patients will develop chylous ascites, which results from overdistension and consequent rupture
of lymphatic cysts. The patient presented with a pelvic lymphagioleiomyoma, prior to pulmonary
involvement.
-Abdominal lymphadenopathies, normally retroperitoneal or retrocural and, occasionally, pelvic are
visible on CT in approximately 33% of patients . These can present, on unenhanced CT, low(3)
attenuation areas indicative of chylous collections or hamartomas. Hamartomas will enhance after
contrast injection. 
LAM is a slowly progressive illness that usually results in death due to respiratory failure. Currently
there is no effective treatment.
Cystic septated masses located in the abdomen or pelvis can be seen in LAM, however the most
common abdominal findings are renal angiomyolipomas.
Final Diagnosis
Pelvic Lymphangioleiomyomatosis
Differential Diagnosis List
Ovarian cyst, Lymphocele
Figures
Figure 1 Pelvic US
Pelvic US showing anechoic mass, with fine septa (arrows). 
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Figure 2 Pelvic CT (Coronal)
CT coronal reconstruction showing hypodense mass (blue arrows) on the right illiac fossa
and right side of the pelvis, which pushes the bladder (B) and uterus (U) to the contralateral
side. 
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Figure 3 Pelvic MR
Cystic septated mass (blue arrow) with enhancing septa (black arrow). (A) Axial T1WI post
paramagnetic contrast injection, (B) axial T2WI with fat saturation, (C) sagittal T2WI and
(D) coronal T2WI. 
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MeSH
 [C04.557.375.460.465]Lymphangiomyomatosis
A progressive disorder of women of child-bearing age, marked by nodular and diffuse interstitial
proliferation of smooth muscle in the lungs, lymph nodes, and thoracic duct. (Dorland, 27th ed)
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